NEW YORK (

TheStreet

) -- Shares of

Pharmaceutical Product Development

(Nasdaq:

PPDI

) were gapping up Monday morning with an open price 14.2% higher than Friday's closing price. The stock closed at $27.86 Friday and opened today's trading at $31.81.

The average volume for Pharmaceutical Product Development has been 760,600 shares per day over the past 30 days. Pharmaceutical Product Development has a market cap of $3.1 billion and is part of the

health care

sector and

health services

industry. Shares are up 2.9% year to date as of the close of trading on Friday.

Pharmaceutical Product Development, Inc., a contract research organization, provides drug discovery, development, and lifecycle management services. It operates in two segments, Development and Laboratory Services. The company has a P/E ratio of 22.9, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Pharmaceutical Product Development as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, increase in net income and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full

Pharmaceutical Product Development Ratings Report

.

Get more investment ideas from our

investment research center

.

Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting

UP

to 95370 or select from

multiple alert options

.

null